Migraine
60 drugs32,625 FAERS reportsMedDRA PT
GET
/api/v1/reaction/migraineReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D008881
A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
Source: U.S. National Library of Medicine — MeSH (Migraine Disorders)
Drugs reporting Migraine (60)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Triprolidine9735%
- 2Estriol36822%
- 3Atogepant1,11118%
- 4Frovatriptan12217%
- 5Eptinezumab1,41317%
- 6Ubrogepant81514%
- 7Zolmitriptan1,01414%
- 8Cobamamide114%
- 9Ferrous Cysteine Glycinate114%
- 10Magnesium Ascorbate114%
- 11Nadh114%
- 12Pyridoxal114%
- 13Threonate114%
- 14Zinc Ascorbate114%
- 15Eletriptan85812%
- 16Ammonia1010%
- 17Galcanezumab2,9639.8%
- 18Viloxazine949.6%
- 19Botulinum Toxin Type A1,1259.4%
- 20Rizatriptan1,4699.3%
- 21Levomilnacipran1749.3%
- 22Erenumab4,9439.2%
- 23Fremanezumab9879.0%
- 24Dihydroergotamine1038.6%
- 25Naratriptan1158.5%
- 26Bacillus Subtilis48.5%
- 27Almotriptan747.8%
- 28Cobalt37.5%
- 29Sumatriptan3,3887.5%
- 30Lasmiditan827.3%
- 31Ergotamine257.2%
- 32Magnesium Citrate4076.9%
- 33Butalbital7936.8%
- 34Rimegepant8346.8%
- 35Pemivibart25.6%
- 36Zavegepant425.2%
- 37Caffeine2,2824.9%
- 38Felodipine5304.8%
- 39Topiramate4,5094.6%
- 40Valerate2834.4%
- 41Elinzanetant44.1%
- 42Butorphanol134.1%
- 43Estetrol94.0%
- 44Methyltestosterone193.7%
- 45Mineral Oil1143.5%
- 46Segesterone123.4%
- 47Milnacipran2013.4%
- 48Pitolisant623.1%
- 49Elagolix1192.8%
- 50Sarecycline52.7%
- 51Florbetapir32.7%
- 52Solriamfetol972.6%
- 53Norethindrone4352.4%
- 54Elbasvir942.2%
- 55Grazoprevir942.2%
- 56Ferrous Fumarate1462.0%
- 57Lumateperone1211.9%
- 58Remibrutinib101.8%
- 59Bremelanotide151.7%
- 60Aceclidine61.4%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Anxiety Disorder7 shared · 0.12
- Catheter Site Irritation7 shared · 0.12
- Foot Operation7 shared · 0.12
- Infusion Site Urticaria7 shared · 0.12
- Parkinson^s Disease Psychosis7 shared · 0.12
- Catheter Site Erythema7 shared · 0.11
- Maternal Exposure Timing Unspecified7 shared · 0.11
- Infusion Site Pain8 shared · 0.11
- Dysarthria7 shared · 0.11
- Muscular Weakness11 shared · 0.11
Literature
Recent PubMed references pinned to Migraine Disorders as a MeSH major topic. About the reaction term itself — not about any specific drug.
- High Mobility Group Box 1 contributes to Neuroinflammation and Central Sensitization After Nitroglycerin Stimulation in Mice.Journal of molecular neuroscience : MN · 2026 · Long T, Zhang S, Yang Y, et al.PMID 42207345DOI 10.1007/s12031-026-02549-2
- Myoinositol and Selenium (MYSE) Supplementation Is Associated with Favorable Changes in Thyroid Parameters and Migraine Outcomes in Patients with Migraine and Hashimoto's Thyroiditis: A Retrospective Cohort Study.Nutrients · 2026 · Di Lorenzo C, Nordio M, Brongo F, et al.PMID 42197013DOI 10.3390/nu18101554
- Antinociceptive Effects of Exogenous and Endogenous Carbon Monoxide in the Nitroglycerin-Induced Migraine Model in Rats.International journal of molecular sciences · 2026 · Ananev A, Gilizhdinova K, Nurmieva D, et al.PMID 42196326DOI 10.3390/ijms27104346
- Associations of Physical Activity and Dietary Habits with Migraine Frequency and Intensity in Adults: A Cross-Sectional Study.Medicina (Kaunas, Lithuania) · 2026 · Murtezani A, Jakupi D, Malaj SR, et al.PMID 42195090DOI 10.3390/medicina62050837
- Exploring Vascular Contributions to Migraine: Association Analysis of Small Vessel Disease Genetic Variants.Genes · 2026 · Molaee Z, Al-Fayyadh M, Smith RA, et al.PMID 42194998DOI 10.3390/genes17050541
- STIM1 GoF Mutants: Genotype-Phenotype Relationships Across the Stormorken/TAM/YPS Spectrum.Cells · 2026 · Atzgerstorfer L, Prantl M, Waldhauser A, et al.PMID 42193934DOI 10.3390/cells15100926
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.